Physiopathologie de l'ischémie cérébrale - Psychologie - M. Fouchey

17-045-A-80 Physiopathologie de l’ischémie cérébrale Neurologie
[42] Heiss WD, Rosner G. Functionnal recovery of cortical
neurons as related to degree and duration of ischemia. Ann
Neurol 1983 ; 14 : 294-301
[43] Hess DC, Hill WD, Martin-Studdard A, Carroll J, Brailer J,
Carothers J. Bone marrow as a source of endothelial cells
and New-expressing cells after stroke. Stroke 2002;33:
1362-1368
[44] Horowitz DR, Tuhrim S, Weinberger JM, Rudolph SH.
Mechanisms in lacunar infarction. Stroke 1992;23:
325-327
[45] Hossman KA. Viability thresholds and the penumbra of
focal ischemia. Ann Neurol 1994 ; 36 : 557-565
[46] Hossmann KA. Periinfarct depolarizations. Cerebrovasc
Brain Metab Rev 1996;8:195-208
[47] Iadecola C. Bright and dark sides of nitric oxide in ischemic
brain injury. Trends Neurosci 1997 ; 20 : 132-139
[48] Iadecola C, Salkowski CA, Zhang F, Aber T, Nagayama M,
Vogel SN et al. The transcription factor interferon regulatory
factor 1 is expressed after cerebral ischemia and contributes
to ischemic brain injury. J Exp Med 1999 ; 189 :
719-727
[49] Johnson TD, Marrelli SP, Steenberg ML, Childres WF, Bryan
RM Jr. Inward rectifier potassium channels in the rat middle
cerebral artery. Am J Physiol 1998 ; 274 : 541-547
[50] Katsura K, Kristian T, Siesjo BK. Energy metabolism, ion
homeostasis, and cell damage in the brain. Biochem Soc
Trans 1994 ; 22 : 991-996
[51] Kim YH, Park JH, Hong SH, Koh JY. Nonproteolytic neuroprotection
by human recombinant tissue plasminogen
activator. Science 1999 ; 284 : 647-650
[52] KleinGM,LiH,SunP,BuchanAM.Tissueplasminogenactivator
does not increase neuronal damage in rat models of
globalandfocalischemia.Neurology1999;52:1381-1384
[53] Kristiàn T, Siesjö BK. Calcium in ischemic cell death. Stroke
1998 ; 29 : 705-718
[54] Larrue V, Amarenco P, Caussanel JP, Ducrocq X, Lucas C,
Mahagne MH et al. Recommandations pour l’utilisation du
traitement thrombolytique intra-veineux dans l’accident
ischémique cérébral. Rev Neurol 2000 ; 156 : 1178-1185
[55] Lazorthe G. Vascularisation et circulation cérébrales. Paris :
Masson, 1961
[56] Lei SZ, Pan ZH, Aggarwal SK, Chen HS, Hartman J, Sucher
NJ et al. Effect of nitric oxide production on the redox
modulatory site of the NMDA receptor-channel complex.
Neuron 1992;8:1087-1099
[57] Leist M, Nicotera P. Apoptosis, excitotoxicity and neuropathology.
Exp Cell Res 1998 ; 239 : 183-201
[58] Lindsberg PJ, Carpen O, Paetau A, Karjalainen-Lindsberg
ML, Kaste M. Endothelial ICAM-1 expression associated
with inflammatory cell response in human ischemic stroke.
Circulation 1996 ; 94 : 939-945
[59] Lindsberg PJ, Hallenbeck JM, Feuerstein G. Plateletactivating
factor in stroke and brain injury. Ann Neurol
1991 ; 30 : 117-129
[60] LoddickSA,RothwellNJ.Neuroprotectiveeffectsofhuman
recombinant interleukin-1 receptor antagonist in focal
cerebral ischaemia in the rat. J Cereb Blood Flow Metab
1996 ; 16 : 932-940
[61] Love S. Oxidative stress in brain ischemia. Brain Pathol
1999;9:119-131
10
[62] Lucas C, Moulin T, Deplanque D, Tatu L, Chavot D, and the
Donald investigators. Stroke patterns of internal carotid
artery dissection in 40 patients. Stroke 1998 ; 29 :
1646-1648
[63] Manjo G, Joris I. Apoptosis, oncosis and necrosis. An overview
of cell death. Am J Pathol 1995 ; 146 : 3-15
[64] Marrelli SP, Johnson TD, Khorovets A, Childres WF, Bryan
RM Jr. Altered function of inward rectifier potassium channels
in cerebrovascular smooth muscle after
ischemia/reperfusion. Stroke 1998 ; 29 : 1469-1474
[65] Martinez-VilaE,SieiraPI.Currentstatusandperspectivesof
neuroprotection in ischemic stroke treatment. Cerebrovasc
Dis 2001 ; 11 (suppl 1) : 60-70
[66] Mies G, Iijima T, Hossmann KA. Correlation between periinfarct
DC shifts and ischaemic neuronal damage in rat.
Neuroreport 1993;4:709-711
[67] Neumann-Haefelin T, Moseley ME, Albers GW. New magnetic
resonance imaging methods for cerebrovascular
disease: emerging clinical applications. Ann Neurol 2000 ;
47 : 559-570
[68] Neumar RW. Molecular mechanisms of ischemic neuronal
injury. Ann Emerg Med 2000 ; 36 : 483-506
[69] Nicole O, Docagne F, Ali C, Margaill I, Carmeliet P, Mackenzie
ET et al. The proteolytic activity of tissueplasminogen
activator enhances NMDA receptormediated
signaling. Nat Med 2001;7:59-64
[70] Nogawa S, Zhang F, Ross ME, Iadecola C. Cyclooxygenase-2
gene expression in neurons contributes to
ischemic brain damage. J Neurosci 1997 ; 17 : 2746-2755
[71] O’Neill LA, Kaltschmidt C. NF-kappa B: a crucial transcription
factor for glial and neuronal cell function. Trends Neurosci
1997 ; 20 : 252-258
[72] Onténiente B. Facteurs neurotrophiques : concepts actuels
et perspectives thérapeutiques. Lett Pharmacol 1997;11:
140-145
[73] PaulsonOB,StandgaardS,EdvinssonL.Cerebralautoregulation.
Cerebrovasc Brain Metab Rev 1990;2:161-192
[74] Pessin MS, Hinton RC, Davis KR, Duncan GW, Roberson
GH, Ackerman RH et al. Mechanisms of acute carotid
stroke. Ann Neurol 1979;6:245-252
[75] Pfefferkorn T, Staufer B, Liebetrau M, Bultemeier G, Vosko
MR, Zimmermann C et al. Plasminogen activation in focal
cerebralischemiaandreperfusion.JCerebBloodFlowMetab
2000 ; 20 : 337-342
[76] Planas AM, Soriano MA, Berruezo M, Justicia C, Estrada A,
Pitarch S et al. Induction of Stat3, a signal transducer and
transcription factor, in reactive microglia following transient
focal cerebral ischaemia. Eur J Neurosci 1996;8:
2612-2618
[77] Ringelstein EB, Koschorke S, Holling A, Thron A, Lambertz
H, Minale C. Computed tomographic patterns of proven
embolic brain infarctions. Ann Neurol 1989 ; 35 : 943-948
[78] Ritter LS, Orozco JA, Coull BM, McDonagh PF, Rosenblum
WI. Leukocyte accumulation and hemodynamic changes
in the cerebral microcirculation during early reperfusion
after stroke. Stroke 2000 ; 31 : 1153-1161
[79] Ruscher K, Isaev N, Trendelenburg G, Weih M, Iurato L,
Meisel A et al. Induction of hypoxia inducible factor 1 by
oxygen glucose deprivation is attenuated by hypoxic preconditioning
in rat cultured neurons. Neurosci Lett 1998 ;
254 : 117-120
[80] Samdani AF, Dawson TM, Dawson VL. Nitric oxide synthase
in models of focal ischemia. Stroke 1997;28:
1283-1288
[81] Samson Y. Cerebral ischemia. Value of measurement of
cerebral blood velocity and of oxygen consumption in
positron emission tomography. Ann Radiol 1992;37:
24-28
[82] Shonewille WJ, Tuhrim S, Singer MB, Atlas SW. Diffusionweighted
MRI in acute lacunar syndromes. A clinicalradiologicalcorrelationstudy.Stroke1999;30:2066-2069
[83] Sims NR, Anderson MF. Mitochondrial contributions to
tissue damage in stroke. Neurochem Int 2002 ; 40 : 511-526
[84] Stoll G, Jander S, Schroeter M. Inflammation and glial
responses in ischemic brain. Prog Neurobiol 1998;56:
149-171
[85] Stone TW, Addae JI. The pharmacological manipulation of
glutamate receptors and neuroprotection. Eur J Pharmacol
2002 ; 447 : 285-296
[86] Torvik A, Skullerud K. How often are brain infarcts caused
by hypotensive episodes. Stroke 1976;7:255-257
[87] Tsirka SE. Clinical implications of the involvement of tPA in
neuronal cell death. J Mol Med 1997 ; 75 : 341-347
[88] Vernieri F, Pasqualetti P, Matteis M, Passarelli F, Troisi E,
Rossini PM et al. Effect of collateral blood flow and cerebral
vasomotor reactivity on the outcome of carotid artery
occlusion. Stroke 2001 ; 32 : 1552-1558
[89] Vivien D, Buisson A. Serine protease inhibitors: novel therapeutic
targets for stroke? J Cereb Blood Flow Metab 2000 ;
20 : 755-764
[90] Wang YF, Tsirka SE, Strickland S, Stieg PE, Soriano SG,
Lipton SA. Tissue plasminogen activator (tPA) increases
neuronal damage after focal cerebral ischemia in wild-type
and tPA-deficient mice. Nat Med 1998;4:228-231
[91] White BC, Sullivan JM, Degracia DJ, O’Neil BJ, Neumar RW,
Grossman LI et al. Brain ischemia and reperfusion: molecular
mechanisms of neuronal injury. J Neurol Sci 2000 ; 179 :
1-33
[92] Wink DA, Hanbauer I, Krishna MC, Degraff W, Gamson J,
Mitchell JB. Nitric oxide protects against cellular damage
and cytotoxicity from reactive oxygen species. Proc Natl
Acad Sci 1993 ; 90 : 9813-9817
[93] Yang GY, Gong C, Qin Z, Ye W, Mao Y, Bertz AL. Inhibition
ofTNFalphaattenuatesinfarctvolumeandICAM-1expression
in ischemic mouse brain. Neuroreport 1998;9:
2131-2134
[94] You R, Mc Neil JJ, O’Malley HM, Davis SM, Donnan GA. Risk
factors for lacunar infarction syndrome. Neurology 1995 ;
45 : 1483-1487
[95] Zaritsky JJ, Eckman DM, Wellman GC, Nelson MT, Schwarz
TL. Targeted disruption of Kir2. 1 and Kir2. 2 genes reveals
the essential role of the inwardly rectifying K (+) current in
K (+)-mediated vasodilation. Circ Res 2000 ; 87 : 160-166
[96] Zhang J, Dawson VL, Dawson TM, Snyder SH. Nitric oxide
activation of poly (ADP-ribose) synthetase in neurotoxicity.
Science 1994 ; 263 : 687-689
[97] Zhang R, Chopp M, Zhang Z, Jiang N, Powers C. The
expression of P- and E-selectins in three models of middle
cerebral artery occlusion. Brain Res 1998 ; 785 : 207-214
[98] Zhang RL, Zhang ZG, Chopp M. Thrombolysis with tissue
plasminogen activators alters adhesion molecule expression
in the ischemic rat brain. Stroke 1999 ; 30 : 624-629
[99] Zhang Z, Chopp M, Goussev A, Powers C. Cerebral vessels
express interleukin 1beta after focal cerebral ischemia.
Brain Res 1998 ; 784 : 210-217
[100] Zhang ZG, Zhang L, Jiang Q, Chopp M. Bone marrowderived
endothelial progenitor cells participate in cerebral
neovascularizationafterfocalcerebralischemiaintheadult
mouse. Circ Res 2002 ; 90 : 284-288